Cultivated Meat and Animal Welfare: The Promise and the Challenges

Cultivated meat, grown from animal cells without slaughter, offers the potential to dramatically reduce farm animal suffering. Understanding its welfare implications helps evaluate this technology.

Key Facts

Cultivated meat is produced by growing animal cells in bioreactors - no animals are slaughtered at scale
Several companies have regulatory approval to sell cultivated chicken in Singapore and the USA
The technology requires a small number of cell biopsies from donor animals
Fetal bovine serum (FBS) from slaughtered calf fetuses has been used in growth media, though alternatives are being developed
Cost reduction from thousands of dollars per kg to commercial price parity is the primary challenge
If successful, cultivated meat could eliminate slaughter for the vast majority of meat consumed

Welfare Considerations

Cultivated meat's welfare potential is extraordinary: if it achieves mainstream adoption, it could end the slaughter of billions of farmed animals annually. The remaining welfare concerns - biopsy of donor animals, FBS use, and conditions of any necessary cell line maintenance - are orders of magnitude smaller than conventional farming. The welfare case for supporting cultivated meat development is strong. The key uncertainties are commercial viability and whether consumers will adopt it at scale. Regulatory approval and supportive policy frameworks in major markets are the most important enabling factors.

What You Can Do

Support cultivated meat development by engaging positively with news and discussions
Donate to Good Food Institute, which supports alternative protein development
Advocate for supportive regulatory frameworks for cultivated meat in the UK and EU
Try cultivated or plant-based meat alternatives when available
Follow progress of companies developing cultivated meat toward commercial viability